FIELD: medicine, diagnostics.
SUBSTANCE: invention relates to field of diagnostics, namely to method for determination of disease duration in case of Q fever in patients under 50. The method for determination of disease duration in case of Q fever consists in the following: in blood serum of patients under 50 activity of catalase is determined at 1 or 2 weeks of the disease, by solution of regression equations of dependence between catalase activity, duration of endotoxicosis and duration of disease, in case of Q fever duration of disease is determined in days; if activity of blood serum catalase is determined at 1 week of disease, duration of disease is determined with 1-2 days accuracy, and if activity of blood serum catalase is determined at 2 weeks of disease - with accuracy up to 1-3 days.
EFFECT: invented method increases accuracy of determination of disease duration in case of Q fever.
3 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING INDICATIONS FOR ADMINISTERING EMOXIPIN IN TREATMENT OF TOXIC DIPHTHERIA | 1998 |
|
RU2137128C1 |
METHOD OF TREATING HAEMORRHAGIC FEVER WITH RENAL SYNDROME | 2008 |
|
RU2379034C1 |
METHOD FOR DETERMINING TOXIC DIPHTHERIA DEVELOPMENT COURSE | 1997 |
|
RU2135998C1 |
METHOD FOR PREDICTING CARDIOVASCULAR DISORDERS DEVELOPMENT RISK AND COURSE IN PATIENTS SUFFERING FROM LEPTOSPIROSIS | 2001 |
|
RU2193342C1 |
THERAPY OF PATIENTS SUFFERING FROM ACUTE BRUCELLOSIS | 2008 |
|
RU2364391C1 |
METHOD OF TREATMENT OF PATIENTS WITH RICKETTSIOSIS | 2000 |
|
RU2171676C1 |
METHOD FOR TREATMENT OF PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROME IN CASE OF LIVER DYSFUNCTION DEVELOPMENT | 2016 |
|
RU2645067C1 |
METHOD FOR TREATING PATIENTS SUFFERING FROM CHRONIC BRUCELLOSIS | 2008 |
|
RU2367490C1 |
METHOD FOR TREATING PATIENTS SUFFERING FROM TYPHOID FEVER | 1994 |
|
RU2044543C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC PANCREATITIS | 2008 |
|
RU2387473C1 |
Authors
Dates
2017-05-03—Published
2016-01-11—Filed